| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Sep 25, 2012 |
|||||||||
| Q3 FY12 | $1.53 | $1.43 | $4.68B | $4.38B |
NYSE |
||||
|
Carnival Corporation & plc
CUK
|
Q3 FY12 | $1.53 | $1.43 | $4.68B | $4.38B |
NYSE |
|||
Jabil
JBL
|
Q4 FY12 | $0.54 | $0.58 | $4.34B | $3.57B |
NYSE |
|||
| Q3 FY12 | $0.93 | $0.93 | $2.58B | $2.58B |
NYSE |
||||
|
Copart
CPRT
|
- | $0.09 | $0.08 | $226.56M | $214.01M |
NASDAQ |
|||
|
FactSet Research Systems
FDS
|
Q4 FY12 | $1.08 | $1.06 | $207.66M | $203.85M |
NYSE |
|||
|
Ennis
EBF
|
- | $0.29 | $0.27 | $138.34M | $128.76M |
NYSE |
|||
|
Vail Resorts
MTN
|
- | -$1.50 | -$1.56 | $113.54M | $118.09M |
NYSE |
|||
|
Neogen
NEOG
|
Q1 FY13 | $0.07 | $0.07 | $49.73M | $46.18M |
NASDAQ |
|||
|
CAMP4 Therapeutics
CAMP
|
- | $0.12 | $0.12 | $43.99M | $43.99M |
NASDAQ |
|||
|
SES AI
SES
|
- | -$6.40 | -$5.12 | $280K | - |
NYSE |
|||
| Show 1 more companies | |||||||||
